Correlation Between Elite Pharma and Anteris Technologies

Can any of the company-specific risk be diversified away by investing in both Elite Pharma and Anteris Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elite Pharma and Anteris Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Elite Pharma and Anteris Technologies Global, you can compare the effects of market volatilities on Elite Pharma and Anteris Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elite Pharma with a short position of Anteris Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elite Pharma and Anteris Technologies.

Diversification Opportunities for Elite Pharma and Anteris Technologies

-0.47

Correlation Coefficient

Elite Pharma  Anteris Technologies

Very good diversification

The 3 months correlation between Elite and Anteris is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Elite Pharma and Anteris Technologies Global in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anteris Technologies and Elite Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elite Pharma are associated (or correlated) with Anteris Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anteris Technologies has no effect on the direction of Elite Pharma i.e., Elite Pharma and Anteris Technologies go up and down completely randomly.

Pair Corralation between Elite Pharma and Anteris Technologies

Given the investment horizon of 90 days Elite Pharma is expected to generate 4.8 times more return on investment than Anteris Technologies. However, Elite Pharma is 4.8 times more volatile than Anteris Technologies Global. It trades about 0.07 of its potential returns per unit of risk. Anteris Technologies Global is currently generating about -0.15 per unit of risk. If you would invest  3.00  in Elite Pharma on October 11, 2024 and sell it today you would earn a total of  0.73  from holding Elite Pharma or generate 24.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	14.06%
Values	Daily Returns

Elite Pharma  vs.  Anteris Technologies Global

Elite Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Elite Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Elite Pharma is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors.

Anteris Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Anteris Technologies Global has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Elite Pharma and Anteris Technologies

The main advantage of trading using opposite Elite Pharma and Anteris Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elite Pharma position performs unexpectedly, Anteris Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anteris Technologies will offset losses from the drop in Anteris Technologies' long position.

The idea behind Elite Pharma and Anteris Technologies Global pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.